Inflammatory responses and inflammation-associated diseases in organs

Medzhitov, 2010, Inflammation 2010: new adventures of an old flame, Cell, 140, 771, 10.1016/j.cell.2010.03.006

Girardin, 2007, Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation, Clin Exp Immunol, 147, 227, 10.1111/j.1365-2249.2006.03261.x

Ding, 2010, Nonresolving inflammation, Cell, 140, 871, 10.1016/j.cell.2010.02.029

Huang, 2016, Triptolide Attenuates Inflammatory Response in Membranous Glomerulo-Nephritis Rat via Downregulation of NF-κB Signaling Pathway, Kidney and Blood Pressure Res, 41, 901, 10.1159/000452591

Akira, 2010, Pattern Recognition Receptors and Inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022

Oppenheim, 2000, Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses, Immunol Rev, 177, 68, 10.1034/j.1600-065X.2000.17702.x

Norman, 2009, Inflammatory pathways in female reproductive health and disease, Reprod, 138, 903, 10.1530/REP-09-0247

Lawrence. The Nuclear Factor NF-κB Pathway in Inflammation. CSH Perspect Biol. 2009. https://doi.org/10.1101/cshperspect.a001651.

Libby, 2007, Inflammatory mechanisms: the molecular basis of inflammation and disease, Nutr Rev, 65, S140, 10.1301/nr.2007.dec.S140-S146

Bracke, 2014, Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease, Annals American Thoracic Society, 11, S322, 10.1513/AnnalsATS.201403-118AW

Gudkov, Komarova. p53 and the Carcinogenicity of Chronic Inflammation. CSH Perspect Med. 2016. https://doi.org/10.1101/cshperspect.a026161.

Matzinger, 2004, Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses, Nat Rev Immunol, 4, 469, 10.1038/nri1372

Aderem, 2000, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors, P Natl Acad Sci, 97, 13766, 10.1073/pnas.250476497

Medzhitov, 2002, Innate immune recognition, Annu rev of immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359

Yamamoto, Takeda. Current Views of Toll-Like Receptor Signaling Pathways. Gastroenterol Res Pract. 2010. https://doi.org/10.1155/2010/240365.

Kwiatkowska, 2014, Toll-Like Receptors and their Contribution to Innate Immunity: Focus on TLR4 Activation by Lipopolysaccharide, Adv Cell Biol, 4, 1, 10.2478/acb-2014-0001

Kaisho, 2001, Toll-like receptors: critical proteins linking innate and acquired immunity, Nat Immunol, 2, 675, 10.1038/90609

Cavaillon, 2007, Stress molecules in sepsis and systemic inflammatory response syndrome, FEBS let, 581, 3723, 10.1016/j.febslet.2007.03.074

Lotze, 2007, Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox, Trends immunol, 28, 429, 10.1016/j.it.2007.08.004

Kaminska, 2005, MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits, BBA, 1754, 253

Aboussekhra, 2016, The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts, Oncotarget, 7, 41974, 10.18632/oncotarget.9633

Avruch, 2001, Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, Physiol Rev, 81, 807, 10.1152/physrev.2001.81.2.807

Jaimovich, 2015, Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells, BBA-Mol Basis Disc, 1852, 1410, 10.1016/j.bbadis.2015.03.012

Sébire, 2009, Role of perinatal inflammation in cerebral palsy, Pediatr neurol, 40, 168, 10.1016/j.pediatrneurol.2008.09.016

Moynagh, 2005, The NF-kB pathway, J Cell Sci, 118, 4585, 10.1242/jcs.02579

Ghosh, 2006, Transcriptional regulation via the NF-|[kappa]|B signaling module, Oncogene, 25, 6706, 10.1038/sj.onc.1209933

Schmidt-Supprian, 2006, Dissection of the NF-κB signalling cascade in transgenic and knockout mice, Cell Death Differ, 13, 861, 10.1038/sj.cdd.4401870

Verma, 2007, A fourth IκB protein within the NF-κB signaling module, Cell, 128, 369, 10.1016/j.cell.2006.12.033

Sebire, 2001, Inflammatory cytokines in the pathogenesis of periventricular leukomalacia, Neurology, 56, 1278, 10.1212/WNL.56.10.1278

Ghosh, 2012, NF-κB, the first quarter-century: remarkable progress and outstanding questions, Gene Dev, 26, 203, 10.1101/gad.183434.111

Kaminska, 2005, MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1754, 253, 10.1016/j.bbapap.2005.08.017

Cobb, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr Rev, 22, 153

Choi, 2010, Pathological roles of MAPK signaling pathways in human diseases, BBA-Mol Basis, 1802, 396, 10.1016/j.bbadis.2009.12.009

Kolch, 2007, MAP kinase signalling pathways in cancer, Oncogene, 26, 3279, 10.1038/sj.onc.1210421

Davis, 2014, TNF, MAP kinase signalling pathways, Semin in Immunol, 26, 237, 10.1016/j.smim.2014.02.009

Davis, 1996, MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway, Mol Cell Biolog, 16, 1247, 10.1128/MCB.16.3.1247

Laurence, 2015, The JAK-STAT pathway: impact on human disease and therapeutic intervention, Annu Rev Med, 66, 311, 10.1146/annurev-med-051113-024537

Smith, 2005, The Jak-STAT pathway in rheumatoid arthritis, J Rheumatol, 32, 1650

Hu, 2003, The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?, Arthritis Rheumatol, 48, 2092, 10.1002/art.11095

Schulz, 2008, The myocardial JAK/STAT pathway: from protection to failure, Pharmacol Therapeut, 120, 172, 10.1016/j.pharmthera.2008.08.002

Ghosh, 2011, Crosstalk in NF-κB signaling pathways, Nat Immunol, 12, 695, 10.1038/ni.2065

Medzhitov, 2004, Toll-like receptor control of the adaptive immune responses, Nat Immunol, 5, 987, 10.1038/ni1112

Suttorp, 2010, Innate immune recognition in infectious and noninfectious diseases of the lung, American J Resp Crit Care Med, 181, 1294, 10.1164/rccm.200909-1427SO

Adcock, 2006, Oxidative stress and redox regulation of lung inflammation in COPD, Eur Respir J, 28, 219, 10.1183/09031936.06.00053805

Harris, Inflammatory markers and onset of cardiovascular events, Circulation, 2003, 2317

Wedzicha, 2000, Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations, Thorax, 55, 114, 10.1136/thorax.55.2.114

Stenvinkel, 2003, Associations between circulating inflammatory markers and residual renal function in CRF patients, Am J Kidney Dis, 41, 1212, 10.1016/S0272-6386(03)00353-6

Ross, 2009, Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy, Cli Infect Dis, 49, 1119, 10.1086/605578

Stampfer, 2004, Inflammatory markers and the risk of coronary heart disease in men and women, New Engl J Med, 351, 2599, 10.1056/NEJMoa040967

Gamarra, 2005, Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension, J Hum Hypertens, 19, 149, 10.1038/sj.jhh.1001785

Stenvinkel, 2008, Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?, Blood Purificat, 26, 291, 10.1159/000126926

Stenvinkel, 2016, Therapeutics targeting persistent inflammation in chronic kidney disease, Translat Res J La Clin Med, 167, 204, 10.1016/j.trsl.2015.06.012

Mcintyre, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psych, 70, 1078, 10.4088/JCP.08r04505

Raison, 2009, Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression, Biol Psych, 65, 732, 10.1016/j.biopsych.2008.11.029

Wallentin, 2000, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease, New Engl J Med, 343, 1139, 10.1056/NEJM200010193431602

Psaty, 2003, Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency, Circulation, 107, 87, 10.1161/01.CIR.0000042700.48769.59

Girndt, 2012, Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC, Clin J Am Soc Nephrolog Cjasn, 7, 1938, 10.2215/CJN.03500412

Pennington, Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease, BBA-Mol Cell Res.2014;, 1843, 2563

Czaja, 2014, Hepatic inflammation and progressive liver fibrosis in chronic liver disease, World J Gastroenter, 20, 2515, 10.3748/wjg.v20.i10.2515

Wang, 2016, Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway, Int Immunopharmacol, 35, 210, 10.1016/j.intimp.2016.04.003

Bell, 2010, Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine, Vet J, 185, 23, 10.1016/j.tvjl.2010.04.009

Yoshioka, 2004, Current research on acute phase proteins in veterinary diagnosis: an overview, Vet J, 168, 28, 10.1016/S1090-0233(03)00119-9

Ohigashi, 2007, Targeting NOX, INOS, COX-2 in inflammatory cells: chemoprevention using food phytochemicals, Int J Cancer, 121, 2357, 10.1002/ijc.23161

Drummond, 2014, A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers, Prog neuro-psychoph, 48, 102, 10.1016/j.pnpbp.2013.09.017

Li, 2010, HMGB1, a potent proinflammatory cytokine in sepsis, Cytokine, 51, 119, 10.1016/j.cyto.2010.02.021

Ottosson, 2011, Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models, Mol Med, 17, 1039, 10.2119/molmed.2010.00264

Zhu, 2017, HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway, Mol Biol Cell, 28, 201, 10.1091/mbc.e16-02-0126

Ma, 2013, The role of HMGB1 in inflammation-mediated organ injury, Acta Anaesthesiol Taiwanica, 51, 28, 10.1016/j.aat.2013.03.007

Lee, 2015, Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK, NF-κB pathways, Neurosci Lett, 584, 191, 10.1016/j.neulet.2014.10.016

Aggarwal, 2010, Oxidative stress, inflammation, and cancer: how are they linked?, Free Radical Biol Med, 49, 1603, 10.1016/j.freeradbiomed.2010.09.006

Martin, 2007, The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair, J Invest Dermatol, 127, 1009, 10.1038/sj.jid.5700811

Tschöpe, 2014, Crosstalk between fibroblasts and inflammatory cells, Cardiovasc Res, 102, 258, 10.1093/cvr/cvu062

Rossi, 2016, Key mechanisms governing resolution of lung inflammation, Semin Immunopathol, 38, 425, 10.1007/s00281-016-0560-6

Nathan, 2006, Neutrophils and immunity: challenges and opportunities, Nat Rev Immunol, 6, 173, 10.1038/nri1785

Kobayashi, 2005, Macrophages in inflammation, Current Drug Targets Inflam Allergy, 4, 281, 10.2174/1568010054022024

Stevens, 1998, Regulation and Function of Mast Cell Proteases in Inflammation, J Clin Immunol, 18, 169, 10.1023/A:1020574820797

Morrell, 2013, Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria, J Immunol, 190, 4685, 10.4049/jimmunol.1202672

Norling, 2015, The resolution of inflammation: Principles and challenges, Semin Immunol, 27, 149, 10.1016/j.smim.2015.03.014

Godson, 2006, Lipoxin A4 redistributes myosin IIA, Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes, Jof Immunol, 176, 1878, 10.4049/jimmunol.176.3.1878

Savill, 2005, Resolution of inflammation: the beginning programs the end, Nat Immunol, 6, 1191, 10.1038/ni1276

Abdulahad, 2014, T cells in vascular inflammatory diseases, Front Immunol, 5, 504

Sugimoto, Sousa, Pinho, Perretti, Teixeira. Resolution of Inflammation: What Controls Its Onset? Front Immuno. 2016. https://doi.org/10.3389/fimmu.2016.00.00160.

Karin, 2011, NF-κB, STAT3 - key players in liver inflammation and cancer, Cell Res, 21, 159, 10.1038/cr.2010.183

Casini, 2016, Mediterranean Diet, 89

Andreslacueva, 2014, Cocoa Polyphenols and Inflammatory Markers of Cardiovascular Disease, Nutrients, 6, 844, 10.3390/nu6020844

Gillespie, 2010, Heart Disease and Stroke Statistics—2010 Update A Report From the American Heart Association, Circulation, 115, e25

Loncar, 2006, Projections of Global Mortality and Burden of Disease from 2002 to 2030, Plos Med, 3, e442, 10.1371/journal.pmed.0030442

Peter, 2008, Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction, Clin Chem, 54, 24, 10.1373/clinchem.2007.097360

Libby, 2012, History of Discovery: Inflammation in Atherosclerosis, Arteriosclerosis Thrombosis Vascular Biology, 32, 2045, 10.1161/ATVBAHA.108.179705

Libby, 2002, Atherosclerosis in Inflammation, Nature, 420, 868, 10.1038/nature01323

Folco, 2010, Inflammation in atherosclerosis: transition from theory to practice, Circulation J, 74, 213, 10.1253/circj.CJ-09-0706

Baugh, 2014, Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target, Heart Fail Rev, 19, 681, 10.1007/s10741-013-9405-8

Aukrust, 2014, Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure, Curr Heart Fail Reports, 11, 146, 10.1007/s11897-014-0185-9

Reimer, 1990, Development of cell injury in sustained acute ischemia, Circulation, 82, II2

Braunwald, 1990, Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications, Circulation, 81, 1161, 10.1161/01.CIR.81.4.1161

Pfeffer, 2006, Controversies in ventricular remodelling, Lancet, 367, 356, 10.1016/S0140-6736(06)68074-4

Frangogiannis, 2008, The immune system and cardiac repair, Pharmacol Res, 58, 88, 10.1016/j.phrs.2008.06.007

Beg, 2002, Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses, Trends Immunol, 23, 509, 10.1016/S1471-4906(02)02317-7

Bauersachs, 2007, Mechanisms of Disease: Toll-like receptors in cardiovascular disease, Nat Clin Pract Card, 4, 444, 10.1038/ncpcardio0938

Hack, 2001, CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?, Int Immunopharmacol, 1, 403, 10.1016/S1567-5769(00)00044-8

Giordano, 2005, Oxygen, oxidative stress, hypoxia, and heart failure, J Clin Invest, 115, 500, 10.1172/JCI200524408

Fitzgerald, 2003, Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS, Circulation, 108, 1912, 10.1161/01.CIR.0000093660.86242.BB

Rogers, 2006, Regulating the regulator: NF-κB signaling in heart, J Mol Cell Cardiol, 41, 580, 10.1016/j.yjmcc.2006.07.006

Rollins, 2001, Chemokines and disease, Nat Immunol, 2, 108, 10.1038/84209

Loetscher, 2001, Lymphocyte traffic control by chemokines, Nat Immunol, 2, 123, 10.1038/84219

Singal, 2009, Biology of TNFα and IL-10, and their imbalance in heart failure, Heart Fail Rev, 14, 113, 10.1007/s10741-008-9104-z

Frangogiannis, 2014, Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: Benefits and perils, J Mol Cell Cardiol, 76, 169, 10.1016/j.yjmcc.2014.09.001

Tu, 2006, Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study, Lancet, 368, 29, 10.1016/S0140-6736(06)68967-8

Goldfine, 2016, Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations, Circulation, 133, 2459, 10.1161/CIRCULATIONAHA.116.022194

Turner, 2017, The identification of TNFR5 as a therapeutic target in diabetes, Taylor Francis, 21, 349

Haranath, 2014, A Review on Diabetes Mellitus Type II, Int J Pharma Res Rev, 3, 23

Donath, 2007, Interleukin-1-receptor antagonist in type 2 diabetes mellitus, New Engl J Med, 356, 1517, 10.1056/NEJMoa065213

Ehses, 2008, Islet inflammation in type 2 diabetes, Diabetes care, 31, S161, 10.2337/dc08-s243

Paquot, 2014, Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes, Diabetes Res Clin Pr, 105, 141, 10.1016/j.diabres.2014.04.006

Mandrup-Poulsen, 2010, Role of IL-1β in type 2 diabetes, Curr Opin Endocrinol, 17, 314, 10.1097/MED.0b013e32833bf6dc

Shoelson, 2011, Type 2 diabetes as an inflammatory disease, Nat Rev Immunol, 11, 98, 10.1038/nri2925

Mishra, 2017, Pathogenic mechanisms of pancreatitis, World J Gastr Pharmacol Therapeut, 8, 10, 10.4292/wjgpt.v8.i1.10

Lowenfels, 2013, The epidemiology of pancreatitis and pancreatic cancer, Gastroenterology, 144, 1252, 10.1053/j.gastro.2013.01.068

Habtezion, 2013, Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma, Gastroenterology, 144, 1230, 10.1053/j.gastro.2012.12.042

Thorlacius, 2013, IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality, J Clin Invest, 123, 1019, 10.1172/JCI64931

Quek, 2015, Whole genomes redefine the mutational landscape of pancreatic cancer, Nature, 518, 495, 10.1038/nature14169

Yan, 2014, Inflammation to cancer: The molecular biology in the pancreas (Review), Oncol Lett, 7, 1747, 10.3892/ol.2014.2003

Cancer, 2004, Chronic pancreatitis and pancreatic cancer, Am J Physiol-Gastr L, 287, G315

Abbruzzese, 2004, Pancreatic cancer, Lancet, 363, 1049, 10.1016/S0140-6736(04)15841-8

Kern, 2000, BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications, Am J pathoL, 156, 1767, 10.1016/S0002-9440(10)65047-X

Xie, 2001, Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells, Oncogene, 20, 3751, 10.1038/sj.onc.1204500

Xie, 2001, Interleukin-8 and human cancer biology, Cytokine Growth F R, 12, 375, 10.1016/S1359-6101(01)00016-8

Kroemer, 2013, Decoding cell death signals in liver inflammation, J Hepatol, 59, 583, 10.1016/j.jhep.2013.03.033

Van Beers, 2016, Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease, Radiology, 283, 98

Dudas, 2008, Physiology and pathophysiology of liver inflammation, damage and repair, J Physiol Pharmacol, 59, 107

Pawlotsky, 2004, Pathophysiology of hepatitis C virus infection and related liver disease, Trends in Microbiol, 12, 96, 10.1016/j.tim.2003.12.005

Adams, 2007, Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, J Exp Med, 204, 667, 10.1084/jem.20061287

Zakhari, 2011, Innate immunity in alcoholic liver disease, Am J Physiol Gastrointest Liver Physiol, 300, 516, 10.1152/ajpgi.00537.2010

Yong, 2011, Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase, Hepatol Res, 41, 683, 10.1111/j.1872-034X.2011.00814.x

Maher, 2009, DAMPs ramp up drug toxicity, J Clin Invest, 119, 246

Mehal, 2012, Sterile Inflammation in the Liver, Gastroenterology, 143, 1158, 10.1053/j.gastro.2012.09.008

Galanos, 1998, Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, science, 282, 2085, 10.1126/science.282.5396.2085

Dolganiuc, 2007, Innate immune response and hepatic inflammation, Seminars in Liver Disease, 27, 339, 10.1055/s-2007-991511

Doherty, 2013, STAT6 and lung inflammation, Jakstat, 2, e25301

Rossi, 2008, Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa, Mucosal Immunol, 1, 350, 10.1038/mi.2008.31

Bracke, 2014, Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease, Annals of the American Thoracic Society, 11, 329

Wood, 2016, Lung inflammation caused by inhaled toxicants: a review, Int J of Copd, 11, 1391

Holownia, 2007, Molecular basis of chronic inflammation in lung diseases: new therapeutic approach, J Physiol Pharmacol, 58, 453

Hoshino, 2016, Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls, Int J Copd, 11, 295

Mayadas, 2016, The Changing Landscape of Renal Inflammation, Trends Mol Med, 22, 151, 10.1016/j.molmed.2015.12.002

Sanchezniño, 2016, NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells, BBA - Mol Basis Dis, 1862, 635, 10.1016/j.bbadis.2016.01.006

Ortiz, 2010, NF-kappaB in renal inflammation, J Am Soc Nephrol, 21, 1254, 10.1681/ASN.2010020218

Kimmel, 2012, Acute kidney injury and chronic kidney disease: an integrated clinical syndrome, Kidney Int, 82, 516, 10.1038/ki.2012.208

Bercik, 2011, Epidemiology and burden of chronic constipation, Can J Gastroenterol, 25, 11B, 10.1155/2011/125491

Umar, 2014, Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013, J Clin Gastroenterol, 48, 567, 10.1097/MCG.0000000000000141

Radford-Smith, 2009, Intestinal barrier dysfunction in inflammatory bowel diseases, Inflamm Bowel Dis, 15, 100, 10.1002/ibd.20539

Podolsky, 2000, Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease, Infection Immunity, 68, 7010, 10.1128/IAI.68.12.7010-7017.2000

Mannon, 2007, The fundamental basis of inflammatory bowel disease, J Clin Invest, 117, 514, 10.1172/JCI30587

Arditi, 2013, The role of pattern recognition receptors in intestinal inflammation, Mucosal Immunol, 6, 451, 10.1038/mi.2013.13

Fitzgerald, 2011, Pattern Recognition Receptors and the Innate Immune Response to Viral Infection, Viruses, 3, 920, 10.3390/v3060920

Sharma, 2008, Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies, Int J Gynecol Cancer, 18, 591, 10.1111/j.1525-1438.2007.01089.x

van der Poll, 2005, Two-way interactions between inflammation and coagulation, Trends Cardiovascular Med, 15, 254, 10.1016/j.tcm.2005.07.004

Kakkar, 2002, Coagulation proteases and human cancer, Biochem Soc T, 30, 201, 10.1042/bst0300201

Lavi, 2002, Microglia in diseases of the central nervous system, Annals Med, 34, 491, 10.1080/078538902321117698

Granata, 2005, Brain Inflammation in Epilepsy: Experimental and Clinical Evidence, Epilepsia, 46, 1724, 10.1111/j.1528-1167.2005.00298.x

Hong, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neuro, 8, 57, 10.1038/nrn2038

Lindvall, 2003, Inflammation is detrimental for neurogenesis in adult brain, P Natl Acad of Sci USA, 100, 13632, 10.1073/pnas.2234031100

Stamatelos, 2001, Cytokines and acute neurodegeneration, Nat Rev Neuro, 2, 734, 10.1038/35094583

Patterson, 2001, The role of cytokines and growth factors in seizures and their sequelae, Prog Neurobio, 63, 125, 10.1016/S0301-0082(00)00022-8